JFL LIFE SCIENCES LIMITED Share Price

JFL LIFE SCIENCES LIMITED Share Price

NSE: JFLLIFE
|
Pharmaceuticals
|
S Cap
₹ 10.45
+0.00 (0.00%)
1D
Last updated 18 Sep, 2026, 13:50 IST

JFL LIFE SCIENCES LIMITED Share Price Today

As of 23 Sep 2026, JFL LIFE SCIENCES LIMITED share price is ₹10.45. The stock opened at ₹10.45, compared to its previous close of ₹10.45. During today's trading session, JFL LIFE SCIENCES LIMITED share price moved in the range of ₹10.45 to ₹10.45, with an average price of ₹10.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹8.55 and a high of ₹15.40.

₹10.45
0.00% up today
₹10.45
1D LOW
1D HIGH

JFL LIFE SCIENCES LIMITED Returns Calculator

Circuit
L
H
₹9.95
₹10.95
52-week
L
H
₹8.55
₹15.40

About JFL LIFE SCIENCES LIMITED

JFL LIFE SCIENCES LIMITED Share Price
ISIN
INE0LA901015
Sector Market Cap
₹ 34.48 Cr

JFL Life Sciences Limited is an India-based pharmaceutical company. The Company's business segment comprises manufacturing and selling of pharmaceutical products. It is engaged in domestic as well as international business. The Company's main product categories include Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet, and capsules (General) and Oral Rehydration Solutions (ORS). Its beta-lactam dry powder injection products include Ampicillin Injection, Cefotaxime Sodium Injection, Cefazoline Sodium Injection, meropenem injection, amoxicillin injection, cefTAZidime injection, flucloxacillin injection, among others. Its beta-lactam tablets and capsule products include Cefadroxil Tablets, Cefadroxil Capsules, among others. Its general tablet and capsule products include Azithromycin Tablets, Iburofen Tablets, Ciprofloxacin Tablets, Ofloxacin Tablets, Paracetamol Tablets, among others. These products are offered in different milligrams (mg).

JFL LIFE SCIENCES LIMITED Financial Highlights

  • Revenue: JFL LIFE SCIENCES LIMITED reported revenue of ₹131.45 crore in FY26 vs ₹82.05 crore in FY25. It showed an increase of 60.21% on a yearly basis.
  • Operating Profit: JFL LIFE SCIENCES LIMITED reported an operating profit of ₹8.60 crore in FY26 vs ₹6.14 crore in FY25. It showed an increase of 40.07% on a year-on-year basis.
  • Net Profit: JFL LIFE SCIENCES LIMITED reported a net profit of ₹6.40 crore in FY26 vs ₹4.16 crore in FY25. It showed an increase of 53.85% on a yearly basis.

JFL LIFE SCIENCES LIMITED Quarterly Result Highlights

  • JFL LIFE SCIENCES LIMITED reported revenue of ₹11.12 crore in Jun 2026, compared with ₹63.09 crore in Mar 2026, representing a decrease of 82.37% on a quarter-on-quarter (QoQ) basis.
  • JFL LIFE SCIENCES LIMITED reported an operating profit of ₹1.49 crore in Jun 2026, compared with ₹2.25 crore in Mar 2026, representing a decrease of 33.78% on a quarter-on-quarter (QoQ) basis.
  • JFL LIFE SCIENCES LIMITED reported a profit of ₹1.11 crore in Jun 2026, compared with ₹1.66 crore in Mar 2026, reflecting a decrease of 33.13% on a QoQ basis.
  • The earnings per share (EPS) of JFL LIFE SCIENCES LIMITED stood at ₹1.26 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
67.47%
FII
0.00%
Other DII
0.00%
Retail and other
32.53%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
34.48
P/E
5.10
P/B
0.75
ROE
13.96%
D/E
0.47
ROCE
15.84%
Div. Yield
0.00%
EPS(TTM)
1.94
Turnover
1.23
EV/EBITDA
4.58
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.36%
Quick Ratio
0.00
Curr. Ratio
2.40
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
JFL Life has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
JFL Life appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

JFL LIFE SCIENCES LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹82.04₹46.55₹42.83₹33.59
Other Income₹0.01₹0.51₹1.64₹0.89
Total Revenue₹82.05₹47.06₹44.47₹34.48
Total Expenses₹75.92₹43.27₹40.75₹30.68
Profit Before Tax₹6.14₹3.79₹3.72₹3.80
Tax₹1.98₹0.49₹0.91₹0.99
Profit After Tax₹4.16₹3.30₹2.81₹2.81
EPS - Basic₹1.26₹1.00₹2.90₹4.12
EPS - Diluted₹1.26₹1.00₹2.90₹4.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹6.13₹3.80₹3.72₹3.80
Income before WC changes₹8.20₹5.05₹5.57₹6.24
Change in Assets-₹16.30-₹1.83-₹2.15-₹18.88
Change in Liabilities₹5.59₹5.19-₹11.49₹14.83
Change in WC-₹10.71₹3.36-₹13.64-₹4.05
Cash flow from Operations-₹3.53₹8.36-₹9.07₹2.32
Cash flow from Investing-₹0.01-₹6.07₹0.87-₹0.71
Cash flow from Financing₹3.54-₹2.31₹8.07-₹1.46
Total Cash Flow₹0.00-₹0.03-₹0.13₹0.15
Cash (Start of the year)₹0.03₹0.06₹0.19₹0.04
Cash (End of the year)₹0.03₹0.03₹0.06₹0.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹12.41₹13.11₹7.93₹8.96
Current Assets₹59.50₹43.60₹41.13₹39.30
Total Assets₹71.91₹56.71₹49.06₹48.26
Current Liabilities₹31.62₹20.63₹15.22₹28.38
Net Current Asset₹27.88₹22.97₹25.91₹10.92
Non-Current Liabilities₹0.84₹0.51₹1.57₹8.59
Equity Capital₹39.46₹35.58₹32.27₹11.29
Total Equity & Liabilities₹71.91₹56.71₹49.06₹48.26
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
3
Neutral
5
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.2
Neutral
ATR (14)
0.37
Neutral
STOCH(9,6)
80
Bearish
STOCH RSI (14)
92.02
Bearish
ADX(9)
28.12
Bearish
UO(9)
52.3
Neutral
ROC(12)
0
Neutral
WillR(14)
-52.94
Neutral
Period
Simple value
Exponential vaue
5D
10.22
10.27
10D
10.11
10.33
20D
10.77
10.7
50D
11.28
10.94
100D
10.31
10.81
Volume trend — traded volume by day
18 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
JFL LIFE SCIENCES LIMITED Share Price
JFL LIFE SCIENCES LIMITED
Pharmaceuticals
Add Stock
Add Another

JFL LIFE SCIENCES LIMITED Share Price FAQs

JFL LIFE SCIENCES LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837